Penumbra
PEN320.3100.26% ( +0.820 )
Penumbra (PEN)
Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. It offers...
- Open
- 320.000
- High
- 321.375
- Low
- 319.740
- Prev. Close
- 319.490
- Volume
- 105.37K
- Turnover
- 33.78M
- Avg Price
- 320.624
- Bid/Ask Ratio
- --
- Amplitude
- 0.51%
- 52wk High
- 362.410
- Volume Ratio
- 0.51
- Turnover Ratio
- 0.28%
Penumbra Analyst Rating
View MoreForecast & Rating
Jul 23, 2026Price forecast
$361.5812.88%
Forecast & RatingHold
16analysts
- Strong buy12.50%
- Buy6.25%
- Hold81.25%
- Sell0.00%
- Strong sell0.00%
News
- Market Beat · Jul 23 at 02:37 AM
California Public Employees Retirement System Increases Position in Penumbra, Inc. $PEN
- PUBT · Jul 22 at 01:35 PM
Penumbra reports THUNDER study results for THUNDERBOLT stroke device
- StockTitan · Jul 22 at 05:35 AM
THUNDER Study Demonstrates Penumbra's THUNDERBOLT is Safe and Effective for Stroke Care | PEN Stock News
- Tip Ranks · Jul 13 at 08:46 PM
Penumbra (PEN) Receives a Hold from RBC Capital
- Simplywall · Jul 10 at 04:32 AM
Is Boston Scientific (BSX) Undervalued Following Its Russell Growth Index Removal?
- Unusual Whales · Jul 7 at 08:04 AM
First Patient Enrolled in Penumbra's FORWARD Study Evaluating Mechanical Thrombectomy and Computer Assisted Vacuum Thrombectomy for Distal Acute Ischemic Stroke
